Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals shares have gained over 50 percent year-to-date. The
company recently announced that LX1033, a treatment for irritable bowel syndrome,
has received “Fast Track” status from the FDA.
Going forward ... (see research report)
Subscribe to News Feeds